Significant Milestone Reached In First NZ CAR T-cell Trial A

The goal of CAR T-cell cancer therapy becoming a standard of care in New Zealand is another step closer with patient enrolment completed and a total of 30 patients treated within the Malaghan Institute’s ENABLE phase 1 safety trial, says Malaghan ...

Related Keywords

Zhaotai , Gansu , China , Australia , Wellington , New Zealand General , New Zealand , United States , American , Australian , Robert Weinkove , American Society Of Hematology , Maurice Wilkins Centre , Wellington Zhaotai Therapies , Malaghan Institute Clinical , Malaghan Institute Of Medical Research , Malaghan Institute , Hunan Zhaotai Medical Group Changsha , Thompson Family Foundation , Malaghan Institute Wellington , Health Research Council , Zealand Ministry Of Business , Significant Milestone Reached In First , Trial Monday , Joint Press , Malaghan Institute Clinical Director Dr Robert , American Society , Wellington Zhaotai Therapies Limited , Bridgewest Ventures , Blood Cancer New Zealand , Maurice Wilkins , Zhaotai Therapies Limited , New Zealand Registered , Hunan Zhaotai Medical Group , Joint Press Release , Health , Health Policy , Medical , Scoop ,